Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Agate JT fund was established in 2016 as a partnership between Agate (Israel) and JT Capital (Beijing; Hong Kong). The fund aims to create value by bridging Israeli advanced technologies in the life science sector with the rapidly growing Chinese healthcare market. It focuses on industrializing Israeli technologies in China to address technological gaps and explore investment opportunities.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Agate JT's primary investment focus?
- Agate JT primarily invests in the Health Tech & Life Sciences sector, with its sole recorded portfolio company, Rapid Medical, operating in this area.
- Can you name a notable company in Agate JT's portfolio?
- Agate JT's portfolio includes Rapid Medical, a company founded in 2008 that develops neurovascular devices.
- What was Agate JT's most recent investment activity?
- Agate JT participated in a Series D funding round for Rapid Medical in April 2019. This was the firm's most recent recorded investment.
- What stage of funding does Agate JT typically participate in?
- Agate JT has participated in a Series C round and a Series D round, indicating an interest in later-stage investments.
- What is the typical check size for Agate JT?
- Agate JT's investment range is between $20M and $20M.
- Where is Agate JT headquartered?
- Agate JT is headquartered in Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2016 |
|---|